ACCP Virtual Journal Club April 2026 – Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment – On Demand
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 1 credit
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- P.O. Box 1758
Top 6 courses
-
2026 Digital Health Webinar1.5 Credits
-
-
-
-
-
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Critical Care Medicine
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Hospital Medicine
- Infectious Disease
- Medical Toxicology
- Metabolic & Bariatric Surgery
- Nephrology
- Neurology
- Obstetrics & Gynecology
- Pediatric Infectious Diseases
- Rheumatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Pediatrics
- Primary care
- Psychiatry
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
-
ReleasedApr 22, 2026
-
Last day to claim creditApr 23, 2029 3 years left
-
American College of Clinical Pharmacology ACCP Virtual Journal Club April 2026 – Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment
-
American College of Clinical Pharmacology ACCP Virtual Journal Club October 2025 – Examining the Impact of Diet-and-Exercise-Induced Weight Loss on Drug Metabolism and Gastric Emptying in Patients with Obesity – On Demand
-
American College of Clinical Pharmacology ACCP Journal CE July 2025 – Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic-Associated Fatty Liver Disease
-
North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Pharmacological Management of Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease January 2025 JPGN
-
Learner’s Digest International (TM) Substance Use Disorder in Advanced Liver Disease/Combined Heart-Liver Transplantation
-
AAHIVM +1 2026 Core Curriculum: Hepatic Comorbidities and HIV
